Current Price Disclosure cycle – 2024 October

Page last updated: 27 September 2024

The 2024 October cycle has a data collection period of 1 October 2023 to 31 March 2024.

Responsible persons must have disclosed brand data to the Price Disclosure Data Administrator (PDDA) by the deadline of 13 May 2024.

The reduction day is 1 October 2024.

Responsible persons should ensure that their authorised representatives keep their details up to date via the Health Products Portal, and sign up to the PBS Newsletter.

Contents

Outcomes of Price Disclosure calculations

The PDDA calculates weighted average disclosed prices (WADPs) to be provided to the Department of Health and Aged Care. The Minister determines WADPs calculated in accordance with the National Health Act 1953 (the Act) and National Health (Pharmaceutical Benefits) Regulations 2017 (the Regulations).

The outcomes reflecting these determinations have been published in a legal determination on the Federal Register of Legislation website.  Price disclosure reductions will apply to brands listed in Schedule 1 of the legal determination. Brands in Schedule 2 of the determination will not take a price disclosure reduction because the percentage difference between their April 2024 PBS approved ex‑manufacturer price and the weighted average disclosed price was below 10% or 30% (as applicable). Any new brands of existing pharmaceutical items with a determination in Schedule 1 that listed after 31 March 2024 will also take the reduction on 1 October 2024 under section 99ADHA of the Act.

Please note an agreed process for responsible persons to raise any questions or concerns arising from an outcome mentioned above is set out in the Price Disclosure Dispute Resolution Administrative Process. The deadline to lodge a dispute is 23 July 2024.

A list of pharmaceutical items scheduled for a price disclosure reduction and their weighted average disclosed prices is presented in the table below.

Legal Instrument Drug

Legal Instrument Form

Legal Instrument MoA

Brands of PI designated brands under 99ADHC (Y/N)

Floor Price

Price reduction applied in 2 previous cycles (Y/N)

Average Unadjusted Price Reduction (UPR) exceeds 12.5% over 3 cycles (Y/N)

April 2024 AEMP

October 2024 AEMP

Percentage difference between April 2024 and October 2024 AEMP (%)

UPR threshold (%)

Calculations based on:
OWAPD = all brand data
GWAPD = originator brand data removed

Aciclovir

Tablet 200 mg

Oral

Y

$5.54

N

Y

$5.54

$4.70

15.16%

10.00%

OWAPD

Aciclovir

Tablet 800 mg

Oral

Y

$24.12

N

Y

$24.12

$20.48

15.09%

10.00%

OWAPD

Ambrisentan

Tablet 10 mg

Oral

N

-

-

-

$1,652.15

$1,381.53

16.38%

10.00%

GWAPD

Ambrisentan

Tablet 5 mg

Oral

N

-

-

-

$1,652.15

$1,381.53

16.38%

10.00%

GWAPD

Amisulpride

Tablet 100 mg

Oral

Y

$5.50

N

Y

$5.50

$4.75

13.64%

10.00%

GWAPD

Amisulpride

Tablet 200 mg

Oral

Y

$23.72

N

Y

$23.72

$20.48

13.66%

10.00%

GWAPD

Amisulpride

Tablet 400 mg

Oral

Y

$43.01

N

Y

$43.01

$37.14

13.65%

10.00%

GWAPD

Azathioprine

Tablet 25 mg

Oral

Y

$9.32

N

Y

$9.32

$7.80

16.31%

10.00%

GWAPD

Azathioprine

Tablet 50 mg

Oral

Y

$15.88

N

Y

$15.88

$13.29

16.31%

10.00%

GWAPD

Bendamustine

Powder for injection containing bendamustine hydrochloride 100 mg

Injection

N

-

-

-

$575.21

$124.07

78.43%

10.00%

OWAPD

Bendamustine

Powder for injection containing bendamustine hydrochloride 25 mg

Injection

N

-

-

-

$143.81

$31.02

78.43%

10.00%

OWAPD

Bevacizumab

Solution for I.V. infusion 100 mg in 4 mL

Injection

N

-

-

-

$90.32

$61.77

31.61%

10.00%

OWAPD

Bevacizumab

Solution for I.V. infusion 400 mg in 16 mL

Injection

N

-

-

-

$361.27

$247.07

31.61%

10.00%

OWAPD

Bortezomib

Powder for injection 2.5 mg

Injection

N

-

-

-

$55.34

$28.47

48.55%

10.00%

OWAPD

Bortezomib

Powder for injection 3.5 mg

Injection

N

-

-

-

$77.47

$39.85

48.56%

10.00%

OWAPD

Bortezomib

Solution for injection 2.5 mg in 1 mL

Injection

N

-

-

-

$55.34

$28.47

48.55%

10.00%

OWAPD

Bortezomib

Solution for injection 3.5 mg in 1.4 mL

Injection

N

-

-

-

$77.47

$39.85

48.56%

10.00%

OWAPD

Clopidogrel with aspirin

Tablet 75 mg (as hydrogen sulfate)-100 mg

Oral

Y

$4.07

N

Y

$4.07

$4.00

1.72%

10.00%

OWAPD

Clozapine

Tablet 100 mg

Oral

Y

$121.19

N

Y

$121.19

$104.04

14.15%

10.00%

GWAPD

Clozapine

Tablet 200 mg

Oral

Y

$242.38

N

Y

$242.38

$208.08

14.15%

10.00%

GWAPD

Clozapine

Tablet 25 mg

Oral

Y

$32.32

N

Y

$32.32

$27.75

14.14%

10.00%

GWAPD

Clozapine

Tablet 50 mg

Oral

Y

$64.64

N

Y

$64.64

$55.49

14.16%

10.00%

GWAPD

Dasatinib

Tablet 100 mg

Oral

N

-

-

-

$1,770.45

$1,197.56

32.36%

10.00%

OWAPD

Dasatinib

Tablet 20 mg

Oral

N

-

-

-

$1,074.89

$727.08

32.36%

10.00%

OWAPD

Dasatinib

Tablet 50 mg

Oral

N

-

-

-

$1,770.45

$1,197.56

32.36%

10.00%

OWAPD

Dasatinib

Tablet 70 mg

Oral

N

-

-

-

$2,191.93

$1,482.66

32.36%

10.00%

OWAPD

Desvenlafaxine

Tablet (extended release) 100 mg (as succinate)

Oral

Y

$9.42

N

Y

$9.42

$7.92

15.92%

10.00%

OWAPD

Desvenlafaxine

Tablet (extended release) 50 mg (as succinate)

Oral

Y

$7.67

N

Y

$7.67

$6.45

15.91%

10.00%

OWAPD

Desvenlafaxine

Tablet (modified release) 100 mg

Oral

Y

$9.42

N

Y

$9.42

$7.92

15.92%

10.00%

OWAPD

Desvenlafaxine

Tablet (modified release) 100 mg (as benzoate)

Oral

Y

$9.42

N

Y

$9.42

$7.92

15.92%

10.00%

OWAPD

Desvenlafaxine

Tablet (modified release) 50 mg

Oral

Y

$7.67

N

Y

$7.67

$6.45

15.91%

10.00%

OWAPD

Desvenlafaxine

Tablet (modified release) 50 mg (as benzoate)

Oral

Y

$7.67

N

Y

$7.67

$6.45

15.91%

10.00%

OWAPD

Diltiazem

Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg

Oral

Y

$6.25

N

Y

$6.25

$5.39

13.76%

10.00%

GWAPD

Diltiazem

Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg

Oral

Y

$8.45

N

Y

$8.45

$7.29

13.73%

10.00%

GWAPD

Dimethyl fumarate

Capsule (modified release) 120 mg

Oral

N

-

-

-

$154.25

$114.62

25.69%

10.00%

GWAPD

Dimethyl fumarate

Capsule (modified release) 240 mg

Oral

N

-

-

-

$594.89

$392.81

33.97%

10.00%

GWAPD

Fenofibrate

Tablet 145 mg

Oral

Y

$8.48

N

Y

$8.48

$6.95

18.04%

10.00%

GWAPD

Fenofibrate

Tablet 48 mg

Oral

Y

$5.66

N

Y

$5.66

$4.64

18.02%

10.00%

GWAPD

Filgrastim

Injection 300 micrograms in 0.5 mL single-use pre-filled syringe

Injection

Y

$71.97

N

Y

$71.97

$58.73

18.40%

10.00%

GWAPD

Filgrastim

Injection 480 micrograms in 0.5 mL single-use pre-filled syringe

Injection

Y

$115.36

N

Y

$115.36

$94.15

18.39%

10.00%

GWAPD

Fingolimod

Capsule 500 micrograms (as hydrochloride)

Oral

N

-

-

-

$951.05

$829.79

12.75%

10.00%

OWAPD

Flecainide

Tablet containing flecainide acetate 100 mg

Oral

N

-

-

-

$18.52

$15.98

13.71%

10.00%

GWAPD

Flecainide

Tablet containing flecainide acetate 50 mg

Oral

N

-

-

-

$14.94

$12.89

13.72%

10.00%

GWAPD

Fulvestrant

Injection 250 mg in 5 mL pre-filled syringe

Injection

N

-

-

-

$193.73

$164.59

15.04%

10.00%

OWAPD

Gabapentin

Capsule 300 mg

Oral

Y

$10.69

N

Y

$10.69

$8.97

16.09%

10.00%

GWAPD

Gabapentin

Capsule 400 mg

Oral

Y

$14.57

N

Y

$14.57

$12.23

16.06%

10.00%

GWAPD

Gabapentin

Tablet 800 mg

Oral

Y

$30.83

N

Y

$30.83

$25.88

16.06%

10.00%

GWAPD

Ganirelix

Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe

Injection

N

-

-

-

$28.76

$24.77

13.87%

10.00%

GWAPD

Glatiramer

Injection containing glatiramer acetate 40 mg in 1 mL single dose pre-filled pen

Injection

N

-

-

-

$584.71

$522.96

10.56%

10.00%

GWAPD

Glatiramer

Injection containing glatiramer acetate 40 mg in 1 mL single dose pre-filled syringe

Injection

N

-

-

-

$549.71

$491.66

10.56%

10.00%

GWAPD

Icatibant

Injection 30 mg (as acetate) in 3 mL single use pre-filled syringe

Injection

N

-

-

-

$749.33

$579.16

22.71%

10.00%

OWAPD

Lacosamide

Tablet 100 mg

Oral

N

-

-

-

$20.13

$16.57

17.69%

10.00%

OWAPD

Lacosamide

Tablet 150 mg

Oral

N

-

-

-

$30.18

$24.85

17.66%

10.00%

OWAPD

Lacosamide

Tablet 200 mg

Oral

N

-

-

-

$160.98

$132.53

17.67%

10.00%

OWAPD

Lacosamide

Tablet 50 mg

Oral

N

-

-

-

$10.06

$8.28

17.69%

10.00%

OWAPD

Lamivudine

Tablet 100 mg

Oral

Y

$26.75

N

Y

$26.75

$23.44

12.37%

10.00%

GWAPD

Lamivudine

Tablet 150 mg

Oral

Y

$50.50

N

Y

$50.50

$44.26

12.36%

10.00%

GWAPD

Lamivudine

Tablet 300 mg

Oral

Y

$50.50

N

Y

$50.50

$44.26

12.36%

10.00%

GWAPD

Lenalidomide

Capsule 10 mg

Oral

N

-

-

-

$886.72

$669.88

24.45%

10.00%

OWAPD

Lenalidomide

Capsule 15 mg

Oral

N

-

-

-

$1,067.96

$806.80

24.45%

10.00%

OWAPD

Lenalidomide

Capsule 25 mg

Oral

N

-

-

-

$1,397.25

$1,055.57

24.45%

10.00%

OWAPD

Lenalidomide

Capsule 5 mg

Oral

N

-

-

-

$676.86

$511.34

24.45%

10.00%

OWAPD

Macrogol 3350

Sachets containing powder for oral solution 13.125 g with electrolytes, 30

Oral

Y

$7.04

N

Y

$7.04

$5.83

17.19%

10.00%

GWAPD

Morphine

Injection containing morphine hydrochloride trihydrate 100 mg in 5 mL

Injection

N

-

-

-

$18.80

$16.91

10.05%

10.00%

OWAPD

Moxonidine

Tablet 200 micrograms

Oral

Y

$5.06

N

Y

$5.06

$4.22

16.60%

10.00%

GWAPD

Moxonidine

Tablet 400 micrograms

Oral

Y

$8.62

N

Y

$8.62

$7.19

16.59%

10.00%

GWAPD

Naloxone

Injection containing naloxone hydrochloride 400 micrograms in 1 mL ampoule

Injection

Y

$20.56

N

Y

$20.56

$16.22

21.11%

10.00%

OWAPD

Olanzapine

Tablet 10 mg

Oral

Y

$7.55

N

Y

$7.55

$6.34

16.03%

10.00%

GWAPD

Olanzapine

Tablet 10 mg (orally disintegrating)

Oral

Y

$7.55

N

Y

$7.55

$6.34

16.03%

10.00%

GWAPD

Olanzapine

Tablet 15 mg (orally disintegrating)

Oral

Y

$11.33

N

Y

$11.33

$9.52

15.98%

10.00%

GWAPD

Olanzapine

Tablet 20 mg (orally disintegrating)

Oral

Y

$15.11

N

Y

$15.11

$12.69

16.02%

10.00%

GWAPD

Olanzapine

Tablet 7.5 mg

Oral

Y

$5.67

N

Y

$5.67

$4.76

16.05%

10.00%

GWAPD

Olanzapine

Wafer 10 mg

Oral

Y

$7.55

N

Y

$7.55

$6.34

16.03%

10.00%

GWAPD

Olanzapine

Wafer 15 mg

Oral

Y

$11.33

N

Y

$11.33

$9.52

15.98%

10.00%

GWAPD

Olanzapine

Wafer 20 mg

Oral

Y

$15.11

N

Y

$15.11

$12.69

16.02%

10.00%

GWAPD

Olmesartan with amlodipine

Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate)

Oral

N

-

-

-

$6.39

$5.56

12.99%

10.00%

GWAPD

Olmesartan with amlodipine

Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate)

Oral

N

-

-

-

$5.96

$5.18

13.09%

10.00%

GWAPD

Pegfilgrastim

Injection 6 mg in 0.6 mL single use pre-filled syringe

Injection

Y

$118.44

N

Y

$118.44

$91.63

22.64%

10.00%

OWAPD

Pirfenidone

Tablet 267 mg

Oral

N

-

-

-

$177.05

$150.26

15.13%

10.00%

OWAPD

Pirfenidone

Tablet 801mg

Oral

N

-

-

-

$531.17

$450.80

15.13%

10.00%

OWAPD

Pomalidomide

Capsule 2 mg

Oral

N

-

-

-

$1,243.81

$1,108.61

10.87%

10.00%

OWAPD

Pomalidomide

Capsule 3 mg

Oral

N

-

-

-

$1,865.72

$1,662.92

10.87%

10.00%

OWAPD

Pomalidomide

Capsule 4 mg

Oral

N

-

-

-

$2,487.62

$2,217.22

10.87%

10.00%

OWAPD

Posaconazole

Tablet (modified release) 100 mg

Oral

N

-

-

-

$136.60

$104.77

23.30%

10.00%

OWAPD

Pregabalin

Capsule 150 mg

Oral

Y

$9.20

N

Y

$9.20

$7.19

21.85%

10.00%

GWAPD

Pregabalin

Capsule 300 mg

Oral

Y

$13.72

N

Y

$13.72

$10.72

21.87%

10.00%

GWAPD

Pregabalin

Capsule 75 mg

Oral

Y

$5.99

N

Y

$5.99

$4.68

21.87%

10.00%

GWAPD

Quetiapine

Tablet (modified release) 150 mg (as fumarate)

Oral

Y

$11.11

N

Y

$11.11

$9.55

14.04%

10.00%

GWAPD

Quetiapine

Tablet (modified release) 200 mg (as fumarate)

Oral

Y

$22.87

N

Y

$22.87

$19.65

14.08%

10.00%

GWAPD

Quetiapine

Tablet (modified release) 300 mg (as fumarate)

Oral

Y

$29.37

N

Y

$29.37

$25.23

14.10%

10.00%

GWAPD

Quetiapine

Tablet (modified release) 400 mg (as fumarate)

Oral

Y

$40.04

N

Y

$40.04

$34.40

14.09%

10.00%

GWAPD

Quetiapine

Tablet (modified release) 50 mg (as fumarate)

Oral

Y

$7.86

N

Y

$7.86

$6.75

14.12%

10.00%

GWAPD

Quetiapine

Tablet 100 mg (as fumarate)

Oral

Y

$11.11

N

Y

$11.11

$9.55

14.04%

10.00%

GWAPD

Quetiapine

Tablet 200 mg (as fumarate)

Oral

Y

$15.14

N

Y

$15.14

$13.01

14.07%

10.00%

GWAPD

Quetiapine

Tablet 300 mg (as fumarate)

Oral

Y

$22.23

N

Y

$22.23

$19.10

14.08%

10.00%

GWAPD

Rasagiline

Tablet 1 mg (as mesilate)

Oral

N

-

-

-

$26.29

$18.67

28.98%

10.00%

GWAPD

Tenofovir

Tablet containing tenofovir disoproxil maleate 300 mg

Oral

Y

$77.46

Y

Y

$77.46

$53.38

31.09%

30.00%

GWAPD

Tenofovir

Tablet containing tenofovir disoproxil phosphate 291 mg

Oral

Y

$77.46

Y

Y

$77.46

$53.38

31.09%

30.00%

GWAPD

Terbinafine

Tablet 250 mg (as hydrochloride)

Oral

Y

$14.29

N

Y

$14.29

$11.88

16.86%

10.00%

GWAPD

Teriflunomide

Tablet 14 mg

Oral

Y

$151.76

Y

Y

$151.76

$96.50

36.41%

30.00%

OWAPD

Valsartan

Tablet 160 mg

Oral

Y

$7.47

N

Y

$7.47

$6.39

14.46%

10.00%

GWAPD

Valsartan

Tablet 320 mg

Oral

Y

$9.58

N

Y

$9.58

$8.19

14.51%

10.00%

GWAPD

Valsartan

Tablet 80 mg

Oral

Y

$5.82

N

Y

$5.82

$4.98

14.43%

10.00%

GWAPD

Vinorelbine

Capsule 20 mg (as tartrate)

Oral

N

-

-

-

$72.12

$46.05

36.15%

10.00%

GWAPD

Vinorelbine

Capsule 30 mg (as tartrate)

Oral

N

-

-

-

$108.80

$69.47

36.15%

10.00%

GWAPD

Voriconazole

Tablet 200 mg

Oral

Y

$264.04

Y

Y

$264.04

$168.54

36.17%

30.00%

GWAPD

Voriconazole

Tablet 50 mg

Oral

Y

$66.01

Y

Y

$66.01

$42.13

36.18%

30.00%

GWAPD

Ziprasidone

Capsule 20 mg (as hydrochloride)

Oral

Y

$32.62

N

Y

$32.62

$27.51

15.67%

10.00%

OWAPD

Ziprasidone

Capsule 40 mg (as hydrochloride)

Oral

Y

$65.36

N

Y

$65.36

$55.12

15.67%

10.00%

OWAPD

Ziprasidone

Capsule 60 mg (as hydrochloride)

Oral

Y

$97.68

N

Y

$97.68

$82.37

15.67%

10.00%

OWAPD

Ziprasidone

Capsule 80 mg (as hydrochloride)

Oral

Y

$130.42

N

Y

$130.42

$109.98

15.67%

10.00%

OWAPD

Flow-on price disclosure reductions

A list of brands of pharmaceutical items that will be subject to an automatic flow-on price disclosure reduction under section 99ADHB of the National Health Act 1953 on 1 October 2024 is available in the Pricing-Combination-Flow-on-Price-Reductions-FED-1-Oct-2024 (Excel 12 KB). Sponsors were able to apply for Ministerial discretion for these reductions to be reduced or not apply. For more information see Ministerial Discretion.

Confirmed prices of brands scheduled for a price disclosure reduction

The Confirmed Prices Reports outlines the approved ex‑manufacturer price for brands scheduled to take a price disclosure reduction. The reports for the 2024 October cycle can be downloaded below.

Brand price reductions and savings to patients

The Brand Price Reductions and Savings to Patients Report outlines the price disclosure reductions per brand and potential savings to non-concessional patients from 1 October 2024. This information is made available to assist patients understand how much they may save on their PBS medicines.

The report does not include any brands of medicines that have other price changes, or brands that are new to the PBS on the reduction day.

The brand price reductions report for the 2024 October cycle can be downloaded below.